LLY
HEALTHCAREEli Lilly and Company
$987.05-1.82 (-0.18%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving LLY Today?
No stock-specific AI insight has been generated for LLY yet. However, LLY was mentioned in the following AI insights:
52-Week Range
$620.46$1,132.06
$987.05
Fundamentals
Market Cap$880.2B
P/E Ratio35.0
EPS$28.18
Dividend Yield0.01%
Dividend / Share$6.23
ROE1.1%
Profit Margin0.4%
Debt / Equity—
Trading
Volume3.9M
Avg Volume (10D)—
Shares Outstanding891.7M
LLY News
96 articles- Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?Motley Fool·May 9, 2026
- How This Eli Lilly-Tied IPO Stock Fared In Its First QuarterYahoo Finance·May 8, 2026
- Eli Lilly's Retatrutide Is So Hot, The Unlaunched Weight-Loss Drug Is Already Getting Knocked OffYahoo Finance·May 8, 2026
- Early Eli Lilly stock investors now earn a 9% dividend yield-on-costThe Street·May 8, 2026
- Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in FocusYahoo Finance·May 8, 2026
- GLP-1 battle heats up between Eli Lilly and Novo NordiskYahoo Finance UK·May 8, 2026
- Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Pharma Sector Sentiment Shift AccuratelySimply Wall Street·May 8, 2026
- Eli Lilly Opening, Growing Lebanon Manufacturing SiteInkFreeNews.com·May 8, 2026
- New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity MarketYahoo Finance·May 8, 2026
- Gene Therapy Briefs: Regeneron Wins FDA Approval for First Neurosensory Gene TherapyGenetic Engineering and Biotechnology News·May 8, 2026
- AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboardFierce Pharma·May 8, 2026
- Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.Motley Fool·May 8, 2026
- Biogen, Eisai hit with 3-month delay for starting SubQ Alzheimer’s therapyBioSpace·May 8, 2026
- Omada Health Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Lilly to invest extra $4.5B across Indiana manufacturingManufacturingdive·May 8, 2026
- Here is Why Eli Lilly (LLY) is One of the Best Stocks to Buy for the Next 15 YearsYahoo Finance·May 8, 2026
- Eli Lilly's (NYSE:LLY) Earnings Are Weaker Than They SeemYahoo Finance·May 8, 2026
- Generali Asset Management SPA SGR Sells 32,367 Shares of Merck & Co., Inc. $MRKMarketBeat·May 8, 2026
- Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific AdvisorYahoo Finance·May 8, 2026
- Why AbCellera Biologics (ABCL) Is Up 16.1% After ABCL635 Trial Momentum Builds Ahead Of DataYahoo Finance·May 7, 2026
- The Agencies Building Pharma's Next Decade Just Picked Their Software: Daily Command Launches With 18 of the Industry's Most Senior Agency Leaders Already Inside ItYahoo Finance·May 7, 2026
- 75 of Pharma's Most Senior Marketers Just Walked Away From a $12 Billion Tool StackYahoo Finance·May 7, 2026
- Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle SupportYahoo Finance·May 7, 2026
- Glucotrack Submits Blood Glucose Monitoring Technology to FDAYahoo Finance·May 7, 2026
- Novo Nordisk Surges 9.2% As Wegovy Pill Fuels MomentumYahoo Finance·May 7, 2026
- Forget Eli Lilly: These 2 Stocks Have More UpsideMotley Fool·May 7, 2026
- Cantor Fitzgerald Lifts PT on Eli Lilly and Company (LLY) on Q1 Earnings CallInsider Monkey·May 7, 2026
- Narrow Tech Leadership Continues as Oil and Rates FallInvesting.com·May 7, 2026
- 3 Reasons It's Not Too Late to Buy Eli Lilly StockThe Motley Fool·May 5, 2026
- Pfizer Stock: Still Priced Like It's Dead MoneyThe Motley Fool·May 3, 2026
- $9 Trillion Is Pouring Into American Manufacturing — And It’s Just Getting StartedGlobeNewswire Inc.·May 3, 2026
- Lilly’s Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentInvesting.com·May 1, 2026
- Deal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens BankruptcyBenzinga·May 1, 2026
- Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026GlobeNewswire Inc.·May 1, 2026
- Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just StartedGlobeNewswire Inc.·Apr 29, 2026
- Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks SoThe Motley Fool·Apr 28, 2026
- Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics LandscapeGlobeNewswire Inc.·Apr 28, 2026
- Is This Deal a Game Changer for Novo Nordisk?The Motley Fool·Apr 28, 2026
- Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli LillyThe Motley Fool·Apr 28, 2026
Price Data
Open$991.35
Previous Close$988.87
Day High$996.49
Day Low$983.50
52 Week High$1,132.06
52 Week Low$620.46
52-Week Range
$620.46$1,132.06
$987.05
Fundamentals
Market Cap$880.2B
P/E Ratio35.0
EPS$28.18
Dividend Yield0.01%
Dividend / Share$6.23
ROE1.1%
Profit Margin0.4%
Debt / Equity—
Trading
Volume3.9M
Avg Volume (10D)—
Shares Outstanding891.7M
About Eli Lilly and Company
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
HEALTHCAREDRUG MANUFACTURERS - GENERAL
Company Details
Security TypeCommon Stock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - GENERAL
CIK—
Composite FIGI—
Share Class FIGI—